Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - PRE-TAX INCOME
Pre-tax Income CRVS - Corvus Pharmaceuticals, Inc.
-27 M
LAST VALUE
20.94%
2 YEAR CAGR
10.45%
5 YEAR CAGR
0.00%
10 YEAR CAGR